Home › Neoplasms by Histologic Type › Texas › Dallas
Neoplasms by Histologic Type clinical trials in Dallas, TX
3 studies for Neoplasms by Histologic Type are looking for participants at sites in and around Dallas (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto
RecruitingObservational study
- UT Southwestern Medical Center, Dallas
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
RecruitingPhase 1
- Texas Oncology - Baylor Charles A. Sammons Cancer Center, Dallas
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
RecruitingPhase 1/2
- UT Southwestern Medical Center, Dallas
Neoplasms by Histologic Type trials in other cities
- Atlanta, GA5 studies
- Boston, MA5 studies
- Houston, TX4 studies
- Los Angeles, CA4 studies
- Chicago, IL4 studies
- St. Louis, MO3 studies
- Baldwin Park, CA3 studies
- San Francisco, CA3 studies
- New York City, NY3 studies
- Tampa, FL3 studies
- Nashville, TN3 studies
- Clifton, NJ3 studies
Other studies in Dallas
- Breast Cancer55 studies
- Non-Small Cell Lung Cancer52 studies
- Metastatic Cancer42 studies
- Heart Failure42 studies
- Cancer (all types)37 studies
- Prostate Cancer36 studies
- Colorectal Cancer33 studies
- Obesity30 studies
- Ovarian Cancer28 studies
- Bladder Cancer27 studies
- Lung Cancer27 studies
- Endometrial Cancer24 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.